Oncology Consulting Services

Bridge works across the entire oncology service line: radiation, medical and surgical oncology, infusion, pharmacy and 340B, imaging, and theranostics. From the treatment room to the boardroom.

Health systems are absorbing reimbursement dislocation, margin compression, and prior authorization friction all at once, usually with siloed point solutions bolted on one at a time. We are a vested partner, not a playbook. We embed alongside your clinical, administrative, and finance teams and solve the total cost of care rather than treating administrative symptoms.

The Math Stopped Working

Oncology programs are absorbing an 18-to-30 percent revenue contraction from uncaptured leakage. Prior authorization has become a high-interest administrative tax on cash flow, with ninety percent of oncology practices adding staff solely to manage the paperwork. The 2026 coding restructure gave payers fresh grounds to re-review work that was already approved.

Most health systems respond by buying another point solution or commissioning another report. Both treat symptoms. Neither addresses why the oncology service line loses money in the first place: clinical operations, reimbursement, compliance, and growth are being managed as four separate problems by four separate teams.

Both Sides of the Table

Oncology cannot be managed effectively from one side of the table. Our defining advantage is rare: experienced oncology clinicians and seasoned healthcare administrators, in the room at the same time. Active clinical authority meets no-nonsense operational and financial grit.

That is how we bridge the trust gap between physicians, administrators, payers, and health systems. It is also why our recommendations survive contact with real volume, real payer scrutiny, and real policy change.

We are independent. No equipment affiliations, no endorsement money, no conflicted incentives shaping our advice.
We are operators, not authors. We do not hand over a static report and walk away.
We say the hard things, including on the issues others avoid.

Five Ways In. One Obligation.

However you come to us, the obligation is the same: the operational, clinical, and financial survival of your oncology program.

Revenue Integrity

Charge capture, prior authorization, and denial prevention across the oncology service line. We rebuild the front end before a denial happens.

Oncology Operations

Workflow, staffing models, chair utilization, and Epic performance built around your actual volume, not a benchmark from a database.

Compliance

Governance, audit defense, and regulatory alignment with CMS, OIG, and DOJ frameworks, structured to protect the growth plan rather than block it.

Service Line Growth

Modality expansion, theranostics, medical oncology integration, and capital strategy pressure-tested against total cost of care before anyone commits.

AI Advisory

Independent vetting, adoption strategy, and cost modeling for AI in oncology, evaluated for workflow fit and regulatory exposure rather than vendor claims.

Start with the problem you can name.

Most engagements begin with a single pressure point: a denial rate that will not move, an authorization backlog, a service line that has stopped growing. We start there, and we find the rest.